Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BIAXIN
- Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
- Clarithromycin Mechanisms in Hypersomnia Syndromes
- Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
- Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
- Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
- Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis
- GEM-CLARIDEX: Ld vs BiRd
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma
- BiRd vs. Rd as Initial Therapy in Multiple Myeloma
- Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort
- Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir
- Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
- CYP3A4 Induction and Mineral Homeostasis
- Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
- Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
- Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
- Clarithromycin for the Treatment of Hypersomnia
- Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
- Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
- Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
- Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- Clarithromycin 500 mg Tablets Under Fasting Conditions
- Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions
- Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions
- Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.
- Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions
- Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
- Comparative Bioavailability Study of Clarithromycin 250 mg Tablets
- Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State
- Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis
- Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis
- Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions
- Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions
- Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
- Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
- Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
- Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
- Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
- Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
- Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
- Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
- Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
- Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
- Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
Clinical trials list
click for details